Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis
ConditionSarcoidosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorDuke University
About this trial
The primary objective of this study was to determine the ability of cardiac magnetic resonance (CMR) to identify cardiac involvement in patients with sarcoidosis. Patients were to undergo CMR in addition to routine clinical evaluation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Biopsy proven sarcoidosis
Suspected cardiac sarcoidosis
Disqualifiers
Contraindication to MRI
Trial population
Patients with biopsy proven sarcoidosis or suspected cardiac sarcoidosis
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
cardiac mortality
Time frame
> 1year2
arrhythmic death
Time frame
> 1year3
Pulmonary mortality
only in subset of patients with pulmonary sarcoidosis
Time frame
> 1yearSecondary outcomes
1
all-cause mortality
Time frame
> 1year2
arrhythmic events
Time frame
> 1year3
Pulmonary Transplant
Time frame
> 1 year4
Cardiac Transplant
Time frame
> 1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov